Aspire Biopharma Holdings Inc. Revenue 2025–2025
Aspire Biopharma Holdings Inc. annual/quarterly revenue history and growth rate from 2025 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Aspire Biopharma Holdings Inc. revenue for the quarter ending March 31, 2026 was 28353.
- Aspire Biopharma Holdings Inc. annual revenue for 2025 was 6202.
Aspire Biopharma Holdings Inc. (ASBP) — Frequently Asked Questions
Aspire Biopharma Holdings Inc. (ASBP) is a publicly traded US company. It has a market capitalization of $9M. In fiscal 2025 it reported revenue of $6,202 and net income of -$24M. Explore ASBP's stock price, financial statements, earnings history, margins and key ratios below.
What is Aspire Biopharma Holdings Inc.'s market cap?
Aspire Biopharma Holdings Inc. (ASBP) has a market capitalization of $9M.
What is the ASBP stock price?
ASBP trades at $6.29 (+12.12% on the day).
How much revenue does Aspire Biopharma Holdings Inc. make?
Aspire Biopharma Holdings Inc. reported revenue of $6,202 in fiscal 2025.
Is ASBP profitable?
In fiscal 2025, Aspire Biopharma Holdings Inc. reported net income of -$24M.